Botulinum Neurotoxins Market Report

Europe Botulinum Neurotoxins Market Size, Status and Forecast 2014-2026

  • POSTDATE：Oct 10, 2019
  • PAGES：177
  • REPORT CODE：GMM311520
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Botulinum Neurotoxins market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 15.5% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Botulinum Neurotoxins Market Segmentations:

    By Player:

    • Alphaeon

    • Revance Therapeutics

    • Transdermal

    • Mentor

    • Allergan

    • CROMA

    • Ipsen

    • Medy-Tox

    • Valeant Pharmaceuticals

    • Malvern Cosmeceutics

    • Nestle

    • Johnson & Johnson

    • Escape Therapeutics

    • Anterios

    • Daewoong Pharmaceutical

    • EpiVax

    • PharmaVital

    • GSK

    • Lipella

    • OBI Pharma

    • Galderma

    • Merz Pharma

    • Eisai

    • Chong Kun Dang

    • CNBG

    • Hugel

    By Type:

    • Botulinum Neurotoxins A (BoNT/A)

    • Botulinum Neurotoxins B (BoNT/B)

    • Botulinum Neurotoxins E (BoNT/E)

    • Botulinum Neurotoxins F (BoNT/F)

    • Botulinum Neurotoxins C (BoNT/C)

    • Botulinum Neurotoxins D (BoNT/D)

    • Botulinum Neurotoxins G (BoNT/G)

    By End-User:

    • Medical Uses

    • Cosmetics

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Botulinum Neurotoxins Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Botulinum Neurotoxins Market Size and Growth Rate of Botulinum Neurotoxins A (BoNT/A) from 2014 to 2026

    • 1.3.2 Europe Botulinum Neurotoxins Market Size and Growth Rate of Botulinum Neurotoxins B (BoNT/B) from 2014 to 2026

    • 1.3.3 Europe Botulinum Neurotoxins Market Size and Growth Rate of Botulinum Neurotoxins E (BoNT/E) from 2014 to 2026

    • 1.3.4 Europe Botulinum Neurotoxins Market Size and Growth Rate of Botulinum Neurotoxins F (BoNT/F) from 2014 to 2026

    • 1.3.5 Europe Botulinum Neurotoxins Market Size and Growth Rate of Botulinum Neurotoxins C (BoNT/C) from 2014 to 2026

    • 1.3.6 Europe Botulinum Neurotoxins Market Size and Growth Rate of Botulinum Neurotoxins D (BoNT/D) from 2014 to 2026

    • 1.3.7 Europe Botulinum Neurotoxins Market Size and Growth Rate of Botulinum Neurotoxins G (BoNT/G) from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Botulinum Neurotoxins Market Size and Growth Rate of Medical Uses from 2014 to 2026

    • 1.4.2 Europe Botulinum Neurotoxins Market Size and Growth Rate of Cosmetics from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Botulinum Neurotoxins Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Botulinum Neurotoxins Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Botulinum Neurotoxins Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Botulinum Neurotoxins Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Botulinum Neurotoxins Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Botulinum Neurotoxins Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Botulinum Neurotoxins Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Botulinum Neurotoxins Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Botulinum Neurotoxins Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Botulinum Neurotoxins Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Botulinum Neurotoxins Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Botulinum Neurotoxins Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Botulinum Neurotoxins Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Botulinum Neurotoxins by Major Types

      • 3.4.1 Market Size and Growth Rate of Botulinum Neurotoxins A (BoNT/A)

      • 3.4.2 Market Size and Growth Rate of Botulinum Neurotoxins B (BoNT/B)

      • 3.4.3 Market Size and Growth Rate of Botulinum Neurotoxins E (BoNT/E)

      • 3.4.4 Market Size and Growth Rate of Botulinum Neurotoxins F (BoNT/F)

      • 3.4.5 Market Size and Growth Rate of Botulinum Neurotoxins C (BoNT/C)

      • 3.4.6 Market Size and Growth Rate of Botulinum Neurotoxins D (BoNT/D)

      • 3.4.7 Market Size and Growth Rate of Botulinum Neurotoxins G (BoNT/G)

    4 Segmentation of Botulinum Neurotoxins Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Botulinum Neurotoxins by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Botulinum Neurotoxins for Medical Uses

      • 4.4.2 Market Size and Growth Rate of Botulinum Neurotoxins for Cosmetics

    5 Market Analysis by Major Regions

    • 5.1 Europe Botulinum Neurotoxins Production Analysis by Top Regions

    • 5.2 Europe Botulinum Neurotoxins Consumption Analysis by Top Regions

    • 5.3 Europe Botulinum Neurotoxins Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Botulinum Neurotoxins Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Botulinum Neurotoxins Production, Import, Consumption and Export Analysis

      • 5.3.3 France Botulinum Neurotoxins Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Botulinum Neurotoxins Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Botulinum Neurotoxins Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Botulinum Neurotoxins Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Botulinum Neurotoxins Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Botulinum Neurotoxins Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Botulinum Neurotoxins Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Botulinum Neurotoxins Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Botulinum Neurotoxins Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Botulinum Neurotoxins Production, Import, Consumption and Export Analysis

    6 Product Circulation of Botulinum Neurotoxins Market among Top Countries

    • 6.1 Top 5 Export Countries in Botulinum Neurotoxins Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Botulinum Neurotoxins Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Botulinum Neurotoxins Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Botulinum Neurotoxins Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Botulinum Neurotoxins Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Botulinum Neurotoxins Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Botulinum Neurotoxins Landscape Analysis

    • 7.1 Germany Botulinum Neurotoxins Landscape Analysis by Major Types

    • 7.2 Germany Botulinum Neurotoxins Landscape Analysis by Major End-Users

    8. UK Botulinum Neurotoxins Landscape Analysis

    • 8.1 UK Botulinum Neurotoxins Landscape Analysis by Major Types

    • 8.2 UK Botulinum Neurotoxins Landscape Analysis by Major End-Users

    9. France Botulinum Neurotoxins Landscape Analysis

    • 9.1 France Botulinum Neurotoxins Landscape Analysis by Major Types

    • 9.2 France Botulinum Neurotoxins Landscape Analysis by Major End-Users

    10. Italy Botulinum Neurotoxins Landscape Analysis

    • 10.1 Italy Botulinum Neurotoxins Landscape Analysis by Major Types

    • 10.2 Italy Botulinum Neurotoxins Landscape Analysis by Major End-Users

    11. Spain Botulinum Neurotoxins Landscape Analysis

    • 11.1 Spain Botulinum Neurotoxins Landscape Analysis by Major Types

    • 11.2 Spain Botulinum Neurotoxins Landscape Analysis by Major End-Users

    12. Poland Botulinum Neurotoxins Landscape Analysis

    • 12.1 Poland Botulinum Neurotoxins Landscape Analysis by Major Types

    • 12.2 Poland Botulinum Neurotoxins Landscape Analysis by Major End-Users

    13. Russia Botulinum Neurotoxins Landscape Analysis

    • 13.1 Russia Botulinum Neurotoxins Landscape Analysis by Major Types

    • 13.2 Russia Botulinum Neurotoxins Landscape Analysis by Major End-Users

    14. Switzerland Botulinum Neurotoxins Landscape Analysis

    • 14.1 Switzerland Botulinum Neurotoxins Landscape Analysis by Major Types

    • 14.2 Switzerland Botulinum Neurotoxins Landscape Analysis by Major End-Users

    15. Turkey Botulinum Neurotoxins Landscape Analysis

    • 15.1 Turkey Botulinum Neurotoxins Landscape Analysis by Major Types

    • 15.2 Turkey Botulinum Neurotoxins Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Botulinum Neurotoxins Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Botulinum Neurotoxins Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Botulinum Neurotoxins Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Botulinum Neurotoxins Landscape Analysis by Top Countries

      • 16.3.1 Denmark Botulinum Neurotoxins Market Volume and Growth Rate

      • 16.3.2 Finland Botulinum Neurotoxins Market Volume and Growth Rate

      • 16.3.3 Norway Botulinum Neurotoxins Market Volume and Growth Rate

      • 16.3.4 Sweden Botulinum Neurotoxins Market Volume and Growth Rate

      • 16.3.6 Iceland Botulinum Neurotoxins Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Botulinum Neurotoxins Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Botulinum Neurotoxins Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Botulinum Neurotoxins Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Botulinum Neurotoxins Landscape Analysis by Top Countries

      • 17.3.1 Belgium Botulinum Neurotoxins Market Volume and Growth Rate

      • 17.3.2 Netherlands Botulinum Neurotoxins Market Volume and Growth Rate

      • 17.3.3 Luxembourg Botulinum Neurotoxins Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Botulinum Neurotoxins Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Botulinum Neurotoxins Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Botulinum Neurotoxins Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Botulinum Neurotoxins Landscape Analysis by Top Countries

      • 18.3.1 Estonia Botulinum Neurotoxins Market Volume and Growth Rate

      • 18.3.2 Latvia Botulinum Neurotoxins Market Volume and Growth Rate

      • 18.3.3 Lithuania Botulinum Neurotoxins Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Alphaeon

      • 19.1.1 Alphaeon Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Revance Therapeutics

      • 19.2.1 Revance Therapeutics Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Transdermal

      • 19.3.1 Transdermal Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Mentor

      • 19.4.1 Mentor Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Allergan

      • 19.5.1 Allergan Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 CROMA

      • 19.6.1 CROMA Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Ipsen

      • 19.7.1 Ipsen Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 Medy-Tox

      • 19.8.1 Medy-Tox Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 Valeant Pharmaceuticals

      • 19.9.1 Valeant Pharmaceuticals Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 Malvern Cosmeceutics

      • 19.10.1 Malvern Cosmeceutics Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    • 19.11 Nestle

      • 19.11.1 Nestle Company Profile and Development Status

      • 19.11.2 Market Performance

      • 19.11.3 Product and Service Introduction

    • 19.12 Johnson & Johnson

      • 19.12.1 Johnson & Johnson Company Profile and Development Status

      • 19.12.2 Market Performance

      • 19.12.3 Product and Service Introduction

    • 19.13 Escape Therapeutics

      • 19.13.1 Escape Therapeutics Company Profile and Development Status

      • 19.13.2 Market Performance

      • 19.13.3 Product and Service Introduction

    • 19.14 Anterios

      • 19.14.1 Anterios Company Profile and Development Status

      • 19.14.2 Market Performance

      • 19.14.3 Product and Service Introduction

    • 19.15 Daewoong Pharmaceutical

      • 19.15.1 Daewoong Pharmaceutical Company Profile and Development Status

      • 19.15.2 Market Performance

      • 19.15.3 Product and Service Introduction

    • 19.16 EpiVax

      • 19.16.1 EpiVax Company Profile and Development Status

      • 19.16.2 Market Performance

      • 19.16.3 Product and Service Introduction

    • 19.17 PharmaVital

      • 19.17.1 PharmaVital Company Profile and Development Status

      • 19.17.2 Market Performance

      • 19.17.3 Product and Service Introduction

    • 19.18 GSK

      • 19.18.1 GSK Company Profile and Development Status

      • 19.18.2 Market Performance

      • 19.18.3 Product and Service Introduction

    • 19.19 Lipella

      • 19.19.1 Lipella Company Profile and Development Status

      • 19.19.2 Market Performance

      • 19.19.3 Product and Service Introduction

    • 19.20 OBI Pharma

      • 19.20.1 OBI Pharma Company Profile and Development Status

      • 19.20.2 Market Performance

      • 19.20.3 Product and Service Introduction

    • 19.21 Galderma

      • 19.21.1 Galderma Company Profile and Development Status

      • 19.21.2 Market Performance

      • 19.21.3 Product and Service Introduction

    • 19.22 Merz Pharma

      • 19.22.1 Merz Pharma Company Profile and Development Status

      • 19.22.2 Market Performance

      • 19.22.3 Product and Service Introduction

    • 19.23 Eisai

      • 19.23.1 Eisai Company Profile and Development Status

      • 19.23.2 Market Performance

      • 19.23.3 Product and Service Introduction

    • 19.24 Chong Kun Dang

      • 19.24.1 Chong Kun Dang Company Profile and Development Status

      • 19.24.2 Market Performance

      • 19.24.3 Product and Service Introduction

    • 19.25 CNBG

      • 19.25.1 CNBG Company Profile and Development Status

      • 19.25.2 Market Performance

      • 19.25.3 Product and Service Introduction

    • 19.26 Hugel

      • 19.26.1 Hugel Company Profile and Development Status

      • 19.26.2 Market Performance

      • 19.26.3 Product and Service Introduction

    The List of Tables and Figures (Totals 110 Figures and 156 Tables)

    • Figure Product Picture

    • Figure Europe Botulinum Neurotoxins Market Size and Growth Rate of Botulinum Neurotoxins A (BoNT/A) from 2014 to 2026

    • Figure Europe Botulinum Neurotoxins Market Size and Growth Rate of Botulinum Neurotoxins B (BoNT/B) from 2014 to 2026

    • Figure Europe Botulinum Neurotoxins Market Size and Growth Rate of Botulinum Neurotoxins E (BoNT/E) from 2014 to 2026

    • Figure Europe Botulinum Neurotoxins Market Size and Growth Rate of Botulinum Neurotoxins F (BoNT/F) from 2014 to 2026

    • Figure Europe Botulinum Neurotoxins Market Size and Growth Rate of Botulinum Neurotoxins C (BoNT/C) from 2014 to 2026

    • Figure Europe Botulinum Neurotoxins Market Size and Growth Rate of Botulinum Neurotoxins D (BoNT/D) from 2014 to 2026

    • Figure Europe Botulinum Neurotoxins Market Size and Growth Rate of Botulinum Neurotoxins G (BoNT/G) from 2014 to 2026

    • Figure Europe Botulinum Neurotoxins Market Size and Growth Rate of Medical Uses from 2014 to 2026

    • Figure Europe Botulinum Neurotoxins Market Size and Growth Rate of Cosmetics from 2014 to 2026

    • Figure Germany Botulinum Neurotoxins Market Size and Growth Rate from 2014 to 2026

    • Figure UK Botulinum Neurotoxins Market Size and Growth Rate from 2014 to 2026

    • Figure France Botulinum Neurotoxins Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Botulinum Neurotoxins Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Botulinum Neurotoxins Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Botulinum Neurotoxins Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Botulinum Neurotoxins Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Botulinum Neurotoxins Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Botulinum Neurotoxins Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Botulinum Neurotoxins Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Botulinum Neurotoxins Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Botulinum Neurotoxins Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Botulinum Neurotoxins Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Botulinum Neurotoxins Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Botulinum Neurotoxins Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Botulinum Neurotoxins Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Botulinum Neurotoxins Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Botulinum Neurotoxins Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Botulinum Neurotoxins Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Botulinum Neurotoxins Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Botulinum Neurotoxins Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Botulinum Neurotoxins Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Botulinum Neurotoxins Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Botulinum Neurotoxins Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Botulinum Neurotoxins Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Botulinum Neurotoxins Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Botulinum Neurotoxins

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Botulinum Neurotoxins by Different Types from 2014 to 2026

    • Table Consumption Share of Botulinum Neurotoxins by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Botulinum Neurotoxins A (BoNT/A)

    • Figure Market Size and Growth Rate of Botulinum Neurotoxins B (BoNT/B)

    • Figure Market Size and Growth Rate of Botulinum Neurotoxins E (BoNT/E)

    • Figure Market Size and Growth Rate of Botulinum Neurotoxins F (BoNT/F)

    • Figure Market Size and Growth Rate of Botulinum Neurotoxins C (BoNT/C)

    • Figure Market Size and Growth Rate of Botulinum Neurotoxins D (BoNT/D)

    • Figure Market Size and Growth Rate of Botulinum Neurotoxins G (BoNT/G)

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Botulinum Neurotoxins by Different End-Users from 2014 to 2026

    • Table Consumption Share of Botulinum Neurotoxins by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Medical Uses

    • Figure Market Size and Growth Rate of Cosmetics

    • Table Europe Botulinum Neurotoxins Production by Major Regions

    • Table Europe Botulinum Neurotoxins Production Share by Major Regions

    • Figure Europe Botulinum Neurotoxins Production Share by Major Countries and Regions in 2014

    • Table Europe Botulinum Neurotoxins Consumption by Major Regions

    • Table Europe Botulinum Neurotoxins Consumption Share by Major Regions

    • Table Germany Botulinum Neurotoxins Production, Import, Consumption and Export Analysis

    • Table UK Botulinum Neurotoxins Production, Import, Consumption and Export Analysis

    • Table France Botulinum Neurotoxins Production, Import, Consumption and Export Analysis

    • Table Italy Botulinum Neurotoxins Production, Import, Consumption and Export Analysis

    • Table Spain Botulinum Neurotoxins Production, Import, Consumption and Export Analysis

    • Table Poland Botulinum Neurotoxins Production, Import, Consumption and Export Analysis

    • Table Russia Botulinum Neurotoxins Production, Import, Consumption and Export Analysis

    • Table Switzerland Botulinum Neurotoxins Production, Import, Consumption and Export Analysis

    • Table Turkey Botulinum Neurotoxins Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Botulinum Neurotoxins Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Botulinum Neurotoxins Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Botulinum Neurotoxins Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Botulinum Neurotoxins Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Botulinum Neurotoxins Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Botulinum Neurotoxins Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Botulinum Neurotoxins Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Botulinum Neurotoxins Consumption by Types from 2014 to 2026

    • Table Germany Botulinum Neurotoxins Consumption Share by Types from 2014 to 2026

    • Table Germany Botulinum Neurotoxins Consumption by End-Users from 2014 to 2026

    • Table Germany Botulinum Neurotoxins Consumption Share by End-Users from 2014 to 2026

    • Table UK Botulinum Neurotoxins Consumption by Types from 2014 to 2026

    • Table UK Botulinum Neurotoxins Consumption Share by Types from 2014 to 2026

    • Table UK Botulinum Neurotoxins Consumption by End-Users from 2014 to 2026

    • Table UK Botulinum Neurotoxins Consumption Share by End-Users from 2014 to 2026

    • Table France Botulinum Neurotoxins Consumption by Types from 2014 to 2026

    • Table France Botulinum Neurotoxins Consumption Share by Types from 2014 to 2026

    • Table France Botulinum Neurotoxins Consumption by End-Users from 2014 to 2026

    • Table France Botulinum Neurotoxins Consumption Share by End-Users from 2014 to 2026

    • Table Italy Botulinum Neurotoxins Consumption by Types from 2014 to 2026

    • Table Italy Botulinum Neurotoxins Consumption Share by Types from 2014 to 2026

    • Table Italy Botulinum Neurotoxins Consumption by End-Users from 2014 to 2026

    • Table Italy Botulinum Neurotoxins Consumption Share by End-Users from 2014 to 2026

    • Table Spain Botulinum Neurotoxins Consumption by Types from 2014 to 2026

    • Table Spain Botulinum Neurotoxins Consumption Share by Types from 2014 to 2026

    • Table Spain Botulinum Neurotoxins Consumption by End-Users from 2014 to 2026

    • Table Spain Botulinum Neurotoxins Consumption Share by End-Users from 2014 to 2026

    • Table Poland Botulinum Neurotoxins Consumption by Types from 2014 to 2026

    • Table Poland Botulinum Neurotoxins Consumption Share by Types from 2014 to 2026

    • Table Poland Botulinum Neurotoxins Consumption by End-Users from 2014 to 2026

    • Table Poland Botulinum Neurotoxins Consumption Share by End-Users from 2014 to 2026

    • Table Russia Botulinum Neurotoxins Consumption by Types from 2014 to 2026

    • Table Russia Botulinum Neurotoxins Consumption Share by Types from 2014 to 2026

    • Table Russia Botulinum Neurotoxins Consumption by End-Users from 2014 to 2026

    • Table Russia Botulinum Neurotoxins Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Botulinum Neurotoxins Consumption by Types from 2014 to 2026

    • Table Switzerland Botulinum Neurotoxins Consumption Share by Types from 2014 to 2026

    • Table Switzerland Botulinum Neurotoxins Consumption by End-Users from 2014 to 2026

    • Table Switzerland Botulinum Neurotoxins Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Botulinum Neurotoxins Consumption by Types from 2014 to 2026

    • Table Turkey Botulinum Neurotoxins Consumption Share by Types from 2014 to 2026

    • Table Turkey Botulinum Neurotoxins Consumption by End-Users from 2014 to 2026

    • Table Turkey Botulinum Neurotoxins Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Botulinum Neurotoxins Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Botulinum Neurotoxins Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Botulinum Neurotoxins Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Botulinum Neurotoxins Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Botulinum Neurotoxins Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Botulinum Neurotoxins Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Botulinum Neurotoxins Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Botulinum Neurotoxins Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Botulinum Neurotoxins Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Botulinum Neurotoxins Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Botulinum Neurotoxins Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Botulinum Neurotoxins Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Botulinum Neurotoxins Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Botulinum Neurotoxins Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Botulinum Neurotoxins Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Botulinum Neurotoxins Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Botulinum Neurotoxins Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Botulinum Neurotoxins Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Botulinum Neurotoxins Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Botulinum Neurotoxins Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Botulinum Neurotoxins Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Botulinum Neurotoxins Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Botulinum Neurotoxins Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Botulinum Neurotoxins Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Botulinum Neurotoxins Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Botulinum Neurotoxins Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Botulinum Neurotoxins Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Botulinum Neurotoxins Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Botulinum Neurotoxins Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Alphaeon

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Alphaeon

    • Figure Sales and Growth Rate Analysis of Alphaeon

    • Figure Revenue and Market Share Analysis of Alphaeon

    • Table Product and Service Introduction of Alphaeon

    • Table Company Profile and Development Status of Revance Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Revance Therapeutics

    • Figure Sales and Growth Rate Analysis of Revance Therapeutics

    • Figure Revenue and Market Share Analysis of Revance Therapeutics

    • Table Product and Service Introduction of Revance Therapeutics

    • Table Company Profile and Development Status of Transdermal

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Transdermal

    • Figure Sales and Growth Rate Analysis of Transdermal

    • Figure Revenue and Market Share Analysis of Transdermal

    • Table Product and Service Introduction of Transdermal

    • Table Company Profile and Development Status of Mentor

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mentor

    • Figure Sales and Growth Rate Analysis of Mentor

    • Figure Revenue and Market Share Analysis of Mentor

    • Table Product and Service Introduction of Mentor

    • Table Company Profile and Development Status of Allergan

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Allergan

    • Figure Sales and Growth Rate Analysis of Allergan

    • Figure Revenue and Market Share Analysis of Allergan

    • Table Product and Service Introduction of Allergan

    • Table Company Profile and Development Status of CROMA

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of CROMA

    • Figure Sales and Growth Rate Analysis of CROMA

    • Figure Revenue and Market Share Analysis of CROMA

    • Table Product and Service Introduction of CROMA

    • Table Company Profile and Development Status of Ipsen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ipsen

    • Figure Sales and Growth Rate Analysis of Ipsen

    • Figure Revenue and Market Share Analysis of Ipsen

    • Table Product and Service Introduction of Ipsen

    • Table Company Profile and Development Status of Medy-Tox

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Medy-Tox

    • Figure Sales and Growth Rate Analysis of Medy-Tox

    • Figure Revenue and Market Share Analysis of Medy-Tox

    • Table Product and Service Introduction of Medy-Tox

    • Table Company Profile and Development Status of Valeant Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Valeant Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Valeant Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Valeant Pharmaceuticals

    • Table Product and Service Introduction of Valeant Pharmaceuticals

    • Table Company Profile and Development Status of Malvern Cosmeceutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Malvern Cosmeceutics

    • Figure Sales and Growth Rate Analysis of Malvern Cosmeceutics

    • Figure Revenue and Market Share Analysis of Malvern Cosmeceutics

    • Table Product and Service Introduction of Malvern Cosmeceutics

    • Table Company Profile and Development Status of Nestle

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Nestle

    • Figure Sales and Growth Rate Analysis of Nestle

    • Figure Revenue and Market Share Analysis of Nestle

    • Table Product and Service Introduction of Nestle

    • Table Company Profile and Development Status of Johnson & Johnson

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson

    • Figure Sales and Growth Rate Analysis of Johnson & Johnson

    • Figure Revenue and Market Share Analysis of Johnson & Johnson

    • Table Product and Service Introduction of Johnson & Johnson

    • Table Company Profile and Development Status of Escape Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Escape Therapeutics

    • Figure Sales and Growth Rate Analysis of Escape Therapeutics

    • Figure Revenue and Market Share Analysis of Escape Therapeutics

    • Table Product and Service Introduction of Escape Therapeutics

    • Table Company Profile and Development Status of Anterios

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Anterios

    • Figure Sales and Growth Rate Analysis of Anterios

    • Figure Revenue and Market Share Analysis of Anterios

    • Table Product and Service Introduction of Anterios

    • Table Company Profile and Development Status of Daewoong Pharmaceutical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Daewoong Pharmaceutical

    • Figure Sales and Growth Rate Analysis of Daewoong Pharmaceutical

    • Figure Revenue and Market Share Analysis of Daewoong Pharmaceutical

    • Table Product and Service Introduction of Daewoong Pharmaceutical

    • Table Company Profile and Development Status of EpiVax

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of EpiVax

    • Figure Sales and Growth Rate Analysis of EpiVax

    • Figure Revenue and Market Share Analysis of EpiVax

    • Table Product and Service Introduction of EpiVax

    • Table Company Profile and Development Status of PharmaVital

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of PharmaVital

    • Figure Sales and Growth Rate Analysis of PharmaVital

    • Figure Revenue and Market Share Analysis of PharmaVital

    • Table Product and Service Introduction of PharmaVital

    • Table Company Profile and Development Status of GSK

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GSK

    • Figure Sales and Growth Rate Analysis of GSK

    • Figure Revenue and Market Share Analysis of GSK

    • Table Product and Service Introduction of GSK

    • Table Company Profile and Development Status of Lipella

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lipella

    • Figure Sales and Growth Rate Analysis of Lipella

    • Figure Revenue and Market Share Analysis of Lipella

    • Table Product and Service Introduction of Lipella

    • Table Company Profile and Development Status of OBI Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of OBI Pharma

    • Figure Sales and Growth Rate Analysis of OBI Pharma

    • Figure Revenue and Market Share Analysis of OBI Pharma

    • Table Product and Service Introduction of OBI Pharma

    • Table Company Profile and Development Status of Galderma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Galderma

    • Figure Sales and Growth Rate Analysis of Galderma

    • Figure Revenue and Market Share Analysis of Galderma

    • Table Product and Service Introduction of Galderma

    • Table Company Profile and Development Status of Merz Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merz Pharma

    • Figure Sales and Growth Rate Analysis of Merz Pharma

    • Figure Revenue and Market Share Analysis of Merz Pharma

    • Table Product and Service Introduction of Merz Pharma

    • Table Company Profile and Development Status of Eisai

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eisai

    • Figure Sales and Growth Rate Analysis of Eisai

    • Figure Revenue and Market Share Analysis of Eisai

    • Table Product and Service Introduction of Eisai

    • Table Company Profile and Development Status of Chong Kun Dang

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Chong Kun Dang

    • Figure Sales and Growth Rate Analysis of Chong Kun Dang

    • Figure Revenue and Market Share Analysis of Chong Kun Dang

    • Table Product and Service Introduction of Chong Kun Dang

    • Table Company Profile and Development Status of CNBG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of CNBG

    • Figure Sales and Growth Rate Analysis of CNBG

    • Figure Revenue and Market Share Analysis of CNBG

    • Table Product and Service Introduction of CNBG

    • Table Company Profile and Development Status of Hugel

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hugel

    • Figure Sales and Growth Rate Analysis of Hugel

    • Figure Revenue and Market Share Analysis of Hugel

    • Table Product and Service Introduction of Hugel

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US